Evidence map›Paper›PMID 42432818›Full record

ArticleAmerican journal of hematology2026

p53 Immunohistochemistry Is a Reliable Method for Assessing TP53 Allelic and Functional Status in TP53-Mutated Cases.

Hong Fang, Joseph D Khoury, Zhenya Tang, Sa A Wang, Courtney D DiNardo, Sanam Loghavi, Wei J Wang, Yiannis Petros Dimopoulos, Shimin Hu, C Cameron Yin and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hong FangDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Joseph D KhouryDepartment of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Zhenya TangDepartment of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Sa A WangDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Courtney D DiNardoDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sanam LoghaviDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wei J WangDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-1957-3226
Yiannis Petros DimopoulosDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Shimin HuDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
C Cameron YinDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Siba El HusseinDepartment of Pathology, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.ORCID https://orcid.org/0000-0002-1338-7107
Hui ZhangDepartment of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Jayastu SenapatiDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-6831-2567
Kelly ChienDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Michael AndreeffDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
L Jeffrey MedeirosDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wei WangDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allelic statuscomplex karyotypeimmunohistochemistrymutationTP53

Identifiers

PMID42432818
PMCPMC13428366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.